Patent · US Active

Substituted benzopiperazines as CETP inhibitors

US9126976B2 · kind B2 · utility

4Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2012
Grant dateSep 8, 2015
Priority date—
Expiry dateAug 13, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having the structure of Formula Ia, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and may be useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.